Results for tag: "Schistosomiasis Drug"

Schistosomiasis is a parasitic infection caused by a group of flatworms known as schistosomes. It is a major public health problem in many parts of the world, particularly in tropical and subtropical regions. Treatment of schistosomiasis is mainly based on the use of antischistosomal drugs, such as praziquantel, oxamniquine, and artemether. These drugs are used to kill the adult worms and reduce the symptoms of the disease. The schistosomiasis drug market is a rapidly growing segment of the infectious diseases drug market. The increasing prevalence of schistosomiasis, the availability of effective drugs, and the rising awareness of the disease are some of the key factors driving the growth of the market. Additionally, the increasing investments in research and development of new drugs and the increasing collaborations between pharmaceutical companies and research institutes are expected to further boost the market growth. Some of the major companies in the schistosomiasis drug market include Merck & Co., Inc., GlaxoSmithKline plc, Sanofi S.A., Bayer AG, Pfizer Inc., Novartis AG, and Johnson & Johnson. Show Less Read more